Samuel Ruben-Peter G. Viele Professor of Engineering; Professor of Chemical Engineering and Molecular Pharmacology and Therapeutics
Jingyue Ju’s research uses molecular science and engineering to create new approaches for highly efficient and cost-effective DNA sequencing, an essential technology for personalized precision medicine. His research also focuses on the development of novel antiviral therapeutics.
As a U.S. Department of Energy Human Genome Distinguished Postdoctoral Fellow at the University of California at Berkeley (1994-5), he pioneered the application of chemistry and fluorescence energy transfer (ET) principle to construct ET molecular tags for high-throughput DNA sequencing and analysis, which was widely used for the completion of the Human Genome Project. He is the inventor of over 80 U.S. patents in genomic technology, including a novel method for single molecule real-time electronic DNA sequencing, which has the potential to accelerate the use of DNA sequencing for wide applications in clinical diagnosis and precision medicine.
The Ju Laboratory focuses on the design and synthesis of novel molecules for biological engineering, imaging and the development of new technologies for genomic research. His team uses a combination of chemical science, engineering principles and experimental biological approaches to pursue these research objectives. They invented several generations of DNA sequencing technologies, including the design and synthesis of cleavable fluorescent nucleotide reversible terminators that enabled the development of the DNA sequencing-by-synthesis platform, the dominant approach used in next-generation sequencing systems, which laid the foundation for the $1,000 genome. Another project involves the use of genomic approaches to decipher memory circuits for the study of brain function, which helps delineate the molecular mechanisms underlying neurological disorders.
His laboratory is also pursuing the design and synthesis of novel nucleotide analogues as antiviral therapeutics. The viral targets include SARS-CoV-2 (which causes COVID-19) and other viral families with high potential to cause future pandemics.
Ju received a BS in Chemistry from Inner Mongolia University in 1985, an MS in Chemistry from the Dalian Institute of Chemical Physics, Chinese Academy of Sciences in 1988, and a PhD in Chemistry from the University of Southern California in 1994. He was a recipient of the Packard Fellowship in Science and Engineering.